Case number 1:23-cv-00710
Otsuka Pharmaceutical Co., Ltd. v. Apotex Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Sep 27, 2023 | 7 | Stipulated Consent Judgment and Injunction, by Otsuka Pharmaceutical Co., Ltd.. (Tigan, Jeremy) Modified on 9/27/2023 (nms). (Entered: 09/27/2023) (3) |
| Sep 27, 2023 | 8 | STIPULATED Consent Judgment and Injunction. Signed by Judge Richard G. Andrews on 9/27/2023. (nms) (Entered: 09/27/2023) (3) |
| Sep 27, 2023 | 9 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,501,730 B2; 8,273,735 B2. (Attachments: # 1 Consent Judgment)(nms) (Entered: 09/27/2023) (0) |
| Jul 5, 2023 | N/A | Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) (Entered: 07/05/2023) (0) |
| Jun 30, 2023 | 1 | Complaint* (1) |
| Jun 30, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (vfm) (Entered: 06/30/2023) (3) |
| Jun 30, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: See Attached. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: See Attached. (vfm) (Entered: 06/30/2023) (2) |
| Jun 30, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,501,730 B2 ;8,273,735 B2. (vfm) (Entered: 06/30/2023) (1) |
| Jun 30, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Otsuka Holdings Co., Ltd. for Otsuka Pharmaceutical Co., Ltd. filed by Otsuka Pharmaceutical Co., Ltd.. (vfm) (Entered: 06/30/2023) (1) |
| Jun 30, 2023 | 6 | Summons Issued as to Apotex Corp. on 6/30/2023; Apotex Inc. on 6/30/2023. (Attachments: # 1 Summons Issued) (vfm) (Entered: 06/30/2023) (0) |
